Literature DB >> 31116127

Anxiety disorders and medical illness comorbidity and treatment implications.

Milan Latas1, Dusanka Vučinić Latas2, Marija Spasić Stojaković3.   

Abstract

PURPOSE OF REVIEW: To review recent studies which assess comorbidity, that is, prevalence of co-occurrence, relationships and treatment implications between anxiety disorders and various medical illnesses. RECENT
FINDINGS: The prevalence rates of anxiety disorders in patients with medical illnesses are high, with percentage up to 29% in patients with epilepsy, 48.9% in patients with multiple sclerosis, 30.1% in patients with Parkinson's disease, 30% in patients with cardiovascular disease, 47.0% in patients with diabetes mellitus, and so on. The most prevalent anxiety disorders among individuals with somatic illnesses are generalized anxiety disorder and panic disorder. In addition, various medical illnesses are highly prevalent in samples of patients with anxiety disorders. Anxiety disorders co-occurring with medical illnesses have a number of clinical implications, including a greater severity and negative impact on treatment outcome of both medical illnesses and anxiety disorders.
SUMMARY: It is important for clinicians to look for possible anxiety disorders among patients with medical illnesses. Further studies need to ascertain how to best treat individuals suffering from both anxiety disorders and medical illnesses, and focus on the issue of causality when these conditions co-occur.

Entities:  

Year:  2019        PMID: 31116127     DOI: 10.1097/YCO.0000000000000527

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  8 in total

1.  Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action.

Authors:  Yane Costa Chaves; Karina Genaro; José Alexandre Crippa; Joice Maria da Cunha; Janaína Menezes Zanoveli
Journal:  Metab Brain Dis       Date:  2021-01-19       Impact factor: 3.584

2.  Influence of Comorbidities on Healthcare Expenditures and Perceived Physical and Mental Health Status Among Adults with Multiple Sclerosis: A Propensity Score-Matched US National-Level Study.

Authors:  Sandipan Bhattacharjee; Zufan Yegezu; Kristin Kollecas; Kevin Duhrkopf; Lobat Hashemi; Nupur Greene
Journal:  Clinicoecon Outcomes Res       Date:  2021-05-13

3.  The association of chronic anxiousness with cardiovascular disease and mortality in the community: results from the Gutenberg Health Study.

Authors:  Iris C Reiner; Ana N Tibubos; Antonia M Werner; Mareike Ernst; Elmar Brähler; Jörg Wiltink; Matthias Michal; Andreas Schulz; Philipp S Wild; Thomas Münzel; Natalie Arnold; Seyed Hamidreza Mahmoudpour; Karl J Lackner; Norbert Pfeiffer; Manfred E Beutel
Journal:  Sci Rep       Date:  2020-07-24       Impact factor: 4.379

Review 4.  The impact of Mental Health Nurse Consultants on the care of general hospital patients experiencing concurrent mental health conditions: An integrative literature review.

Authors:  Julie Sharrock; Brenda Happell; Sarah Yeun-Sim Jeong
Journal:  Int J Ment Health Nurs       Date:  2022-03-23       Impact factor: 5.100

5.  Assessment of anxiety disorders in students starting work with coronavirus patients during a pandemic in Podlaskie Province, Poland.

Authors:  Klaudia Paula Czorniej; Elzbieta Krajewska-Kułak; Wojciech Kułak
Journal:  Front Psychiatry       Date:  2022-08-11       Impact factor: 5.435

6.  Twelve-month outcomes in overweight/obese users with mental disorders following a multi-element treatment including diet, physical activity, and positive thinking: The real-world "An Apple a Day" controlled trial.

Authors:  Laura Giusti; Valeria Bianchini; Annalisa Aggio; Silvia Mammarella; Anna Salza; Stefano Necozione; Alessia Alunno; Claudio Ferri; Massimo Casacchia; Rita Roncone
Journal:  Front Psychiatry       Date:  2022-08-23       Impact factor: 5.435

7.  Implementing changes in mental health among at-risk groups: a decade-long Brazilian roadmap.

Authors:  Claudio N Soares
Journal:  Braz J Psychiatry       Date:  2020-08-03       Impact factor: 2.697

8.  Early-life oxytocin attenuates the social deficits induced by caesarean-section delivery in the mouse.

Authors:  Livia H Morais; Anna V Golubeva; Sophie Casey; Karen A Scott; Ana Paula Ramos Costa; Gerard M Moloney; Timothy G Dinan; John F Cryan
Journal:  Neuropsychopharmacology       Date:  2021-05-26       Impact factor: 7.853

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.